Purchases and Sales Made in Q4 2024 in Vir Biotechnology, Inc. (VIR)
This table provides information about the institutional ownership of Vir Biotechnology, Inc. (VIR) during Q4 2024. The information is specifically focused on institutions that hold shares of Vir Biotechnology, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Feb 13, 2025
Q4 2024
|
Dynamic Technology Lab Private LTD
Singapore, U0 |
SELL
|
- |
-21.6K- 67.65% |
$145K - $219K
|
10.3K
$61.2K
|
|
|
Feb 10, 2025
Q4 2024
|
Ci Private Wealth, LLC
Miami, FL |
SELL
|
- |
-25.5K- 9.02% |
$172K - $260K
|
258K
$1.53M
|
|
|
Feb 13, 2025
Q4 2024
|
Legal & General Group PLC
London, X0 |
SELL
|
- |
-27K- 10.41% |
$182K - $274K
|
232K
$1.38M
|
|
|
Feb 07, 2025
Q4 2024
|
Quest Partners LLC
New York, NY |
SELL
|
- |
-27.5K- 79.79% |
$185K - $280K
|
6.96K
$41.3K
|
|
|
Feb 14, 2025
Q4 2024
|
Two Sigma Investments, LP
New York, NY |
SELL
|
- |
-30.1K- 10.92% |
$203K - $307K
|
246K
$1.46M
|
|
|
Feb 12, 2025
Q4 2024
|
Winton Group LTD
London, X0 |
SELL
|
- |
-38.7K- 29.57% |
$261K - $394K
|
92.2K
$547K
|
|
|
Jan 28, 2025
Q4 2024
|
Empowered Funds, LLC
|
SELL
|
- |
-39.2K- 11.87% |
$264K - $398K
|
291K
$1.72M
|
|
|
Feb 13, 2025
Q4 2024
|
Federated Hermes, Inc.
Pittsburgh, PA |
SELL
|
- |
-44.6K- 87.08% |
$301K - $454K
|
6.62K
$39.3K
|
|
|
Feb 14, 2025
Q4 2024
|
Ameriprise Financial Inc
Minneapolis, MN |
SELL
|
- |
-48.2K- 18.04% |
$325K - $491K
|
219K
$1.3M
|
|
|
Feb 14, 2025
Q4 2024
|
Rafferty Asset Management, LLC
New York, NY |
SELL
|
- |
-53.1K- 30.56% |
$358K - $540K
|
121K
$716K
|
|
|
Feb 14, 2025
Q4 2024
|
Cubist Systematic Strategies, LLC
Stamford, CT |
SELL
|
- |
-54.8K- 31.34% |
$369K - $557K
|
120K
$712K
|
|
|
Feb 14, 2025
Q4 2024
|
Bridgeway Capital Management, LLC
Houston, TX |
SELL
|
- |
-66.5K- 20.18% |
$448K - $677K
|
263K
$1.56M
|
|
|
Feb 14, 2025
Q4 2024
|
Morgan Stanley
New York, NY |
SELL
|
- |
-113K- 9.14% |
$762K - $1.15M
|
1.12M
$6.66M
|
|
|
Feb 14, 2025
Q4 2024
|
Bank Of America Corp
Charlotte, NC |
SELL
|
- |
-143K- 42.47% |
$963K - $1.45M
|
194K
$1.15M
|
|
|
Feb 14, 2025
Q4 2024
|
Ubs Group Ag
|
SELL
|
- |
-143K- 37.34% |
$964K - $1.46M
|
240K
$1.42M
|
|
|
Feb 14, 2025
Q4 2024
|
Nuveen Asset Management, LLC
Chicago, IL |
SELL
|
- |
-162K- 31.1% |
$1.09M - $1.65M
|
360K
$2.13M
|
|
|
Feb 11, 2025
Q4 2024
|
Prudential Financial Inc
Newark, NJ |
SELL
|
- |
-181K- 42.5% |
$1.22M - $1.84M
|
245K
$1.45M
|
|
|
Feb 14, 2025
Q4 2024
|
Algert Global LLC
San Francisco, CA |
SELL
|
- |
-194K- 90.72% |
$1.31M - $1.97M
|
19.8K
$117K
|
|
|
Feb 12, 2025
Q4 2024
|
Wells Fargo & Company
San Francisco, CA |
SELL
|
- |
-199K- 79.08% |
$1.34M - $2.02M
|
52.7K
$312K
|
|
|
Feb 14, 2025
Q4 2024
|
Qube Research & Technologies LTD
London, X0 |
SELL
|
- |
-203K- 56.74% |
$1.37M - $2.07M
|
155K
$919K
|
|
|
Feb 14, 2025
Q4 2024
|
Voloridge Investment Management, LLC
Jupiter, FL |
SELL
|
- |
-206K- 21.08% |
$1.39M - $2.09M
|
770K
$4.56M
|
|
|
Feb 13, 2025
Q4 2024
|
Adar1 Capital Management, LLC
Austin, TX |
SELL
|
- |
-255K- 79.93% |
$1.72M - $2.59M
|
64.1K
$380K
|
|
|
Jan 06, 2025
Q4 2024
|
Nordea Investment Management Ab
Stockholm, V7 |
SELL
|
- |
-287K- 67.74% |
$1.93M - $2.91M
|
136K
$809K
|
|
|
Feb 11, 2025
Q4 2024
|
Goldman Sachs Group Inc
New York, NY |
SELL
|
- |
-316K- 37.9% |
$2.13M - $3.21M
|
517K
$3.07M
|
|
|
Feb 13, 2025
Q4 2024
|
Barclays PLC
London, X0 |
SELL
|
- |
-329K- 59.8% |
$2.22M - $3.35M
|
221K
$1.31M
|
|
|
Feb 14, 2025
Q4 2024
|
Orbimed Advisors LLC
San Diego, CA |
SELL
|
- |
-354K- 9.92% |
$2.39M - $3.6M
|
3.22M
$19.1M
|
|
|
Feb 14, 2025
Q4 2024
|
D. E. Shaw & Co., Inc.
New York, NY |
SELL
|
- |
-429K- 46.06% |
$2.89M - $4.36M
|
502K
$2.98M
|
|
|
Feb 14, 2025
Q4 2024
|
State Street Corp
Boston, MA |
SELL
|
- |
-551K- 9.79% |
$3.71M - $5.6M
|
5.07M
$30.1M
|